Chinese Cannabis-Related Stocks Plunge After Speculative Surge
Shares of Chinese companies linked to cannabis-growing plunged Thursday after the exchange asked several companies to disclose progress on industrial cannabis projects.
More than 20 cannabis-related stocks fell by the 10% daily limit Thursday after a rally since the start of this year boosted stocks that are even remotely linked to the plant, which is still mostly illegal in China.
The Shenzhen Stock Exchange Thursday sent letters to several companies, including Jilin Zixin Pharmaceutical Industrial Co. and Shanghai Shunho New Materials Technology Co., a manufacturer of packaging products that recently obtained an industrial hemp-planting license, asking them to submit progress reports on their industrial cannabis projects by April 2.
Even though growth and consumption of marijuana, the most common product of the cannabis plant, is illegal in China, it is legal to grow industrial hemp, also part of the cannabis family with less than 0.3% tetrahydrocannabinol, the active ingredient in marijuana. Marijuana, cannabis and hemp are all called “da ma” in Chinese, so the three are often confused.
The China National Narcotic Control Commission issued an official notice earlier this month requiring anti-drug authorities to tighten approval of permits for industrial hemp growth. At present, industrial hemp can only be used in fabric and seeds and has never been approved for medical and food use, the regulator said.
Jilin Zixin is a producer of traditional Chinese herbal drugs based in northeastern Jilin province, which is expected to legalize cultivation of industrial cannabis. The company in January announced a cooperation plan with the Jilin Academy of Agriculture Science to develop technology related to industrial hemp.
Jilin Zixin and Shunho plunged more than 6% Thursday. Shares of Jilin Zixin and several other cannabis-related companies have more than doubled this year and Shunho’s shares have nearly quadrupled. Before Thursday’s drop, the stock soared by the 10% daily limit for four consecutive sessions.
Industry insiders said the development prospects for industrial cannabis in China are still unclear, attributing the recent surge of cannabis-related stocks to speculation.
Caixin has noticed large trading volume on cannabis-related stocks in several securities trading rooms well known for hot money traders.
According to East Money Information Co., which tracks stock trading data, a trading room of brokerage house Tibet Orient Fortune Securities Co. in Lhasa, capital of the southwestern Tibet Autonomous Region, bought 204 million yuan ($30.3 billion) of Shunho shares from Feb. 1 to Wednesday and sold 179 million yuan of the stock during the same time.
Large amounts of buying and selling of a stock at the same time indicates market manipulation, in which some investors trade the same stock frequently via multiple accounts to attract other investors to follow, the investment head of a private equity fund told Caixin. This trading style looks like hot-money traders from Zhejiang area, this person said.
Another trading room of brokerage house China Galaxy Securities was also found to have engaged in a large volume of buying and selling of Jilin Zixin’s shares recently. The trading room is commonly believed to be used by Zhao Qiang, known as “Big Brother Zhao” among hot-money traders. Zhao couldn’t be reached to confirm whether some of the transactions were related to him.
Funds started to flow into China’s cannabis sector earlier this year after Canada’s legalization of recreational marijuana and local media reports that northeastern Jilin province is expected to be the third province to allow legal cultivation of industrial hemp in China, after southwestern Yunnan province and northeastern Heilongjiang province.
Contact editor Han Wei (email@example.com)
May 07 08:24 PM
May 07 07:51 PM
May 07 07:39 PM
May 07 04:35 PM
May 06 06:31 PM
May 06 06:25 PM
May 06 06:16 PM
May 05 06:52 PM
May 05 06:46 PM
May 05 06:43 PM
May 04 06:37 PM
May 04 06:34 PM
May 04 05:50 PM
Apr 30 07:05 PM
Apr 30 06:31 PM
- 1Sinopharm’s Vaccine Nears Emergency-Use Approval by WHO
- 2Patchy Risk Disclosure Earns Shanghai Pudong Development Bank a Slap on the Wrist
- 3State Rail Operator Blamed for Beijing Labor Day Chaos
- 4Major Chinese State Firms Told to Keep a Closer Eye on Their Derivative Trading
- 5Illegal Fuel Trade Probe Detains Six Employees of BP’s South China Venture
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas